The Illumina stock price fell by -0.55% on the last day (Wednesday, 30th Dec 2020) from $366.11 to $364.09. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Based on our forecasts, a long-term increase is expected, the "ILMN" stock price prognosis for 2026-01-14 is 512.164 USD. Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]. This suggests that the stock has a possible downside of 18.0%. … The average Illumina stock price prediction forecasts a potential downside of 18.8% from the … On average, they expect Illumina's stock price to reach $333.30 in the next twelve months. Only 0.38% of the stock of Illumina is held by insiders. High institutional ownership can be a signal of strong market trust in this company. Vote “Underperform” if you believe ILMN will underperform the S&P 500 over the long term. What is ILMN's forecast return on equity (ROE) for 2021-2022? Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? View institutional ownership trends for Illumina. Keith Speights (TMFFishBiz) Sep 21, 2020 at 12:15PM Author Bio. ), Illumina has received 921 “underperform” votes. You can opt out at any time. Illumina Inc Stock Price Forecast, "ILMN" Predictons for2021 In 2022, ILMN is forecast to generate $677,732,438,000 in revenue, with the lowest revenue forecast at $653,774,860,000 and the highest revenue forecast at $712,677,100,000. View analysts' price targets for Illumina or view Wall Street analyst' top-rated stocks. Illumina, Inc. (NASDAQ:ILMN) released its quarterly earnings data on Thursday, October, 29th. View insider buying and selling activity for Illumina or or view top insider-buying stocks. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Vote “Outperform” if you believe ILMN will outperform the S&P 500 over the long term. This suggests that the stock … Illumina last announced its earnings data on October 29th, 2020. Company insiders that own Illumina stock include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Phillip G Febbo, Robert P Ragusa, Robert S Epstein, Sam Samad and Susan H Tousi. Their forecasts range from $280.00 to $415.00. Stock Price Forecast The 16 analysts offering 12-month price forecasts for Illumina Inc have a median target of 297.50, with a high estimate of 415.00 and a low estimate of 250.00. Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday. He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…. Illumina's earnings in 2020 is $638,000,000.On average, 4 Wall Street analysts forecast ILMN's earnings for 2021 to be $763,945,000, with the lowest ILMN earnings forecast at $750,440,000, and the highest ILMN earnings forecast at $779,640,000. Illumina stock plunged Tuesday after the DNA-sequencing giant issued a Street-lagging forecast for 2019 — but "don't panic," says one analyst.. X. Illumina trades on the NASDAQ under the ticker symbol "ILMN.". The company went public at $16 per share on July 28, 2000. With a 5-year … Some companies that are related to Illumina include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). The company's average rating score is 2.26, and is based on 8 buy ratings, 8 hold ratings, and 3 sell ratings. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ILMN, but not buy additional shares or sell existing shares. Learn about financial terms, types of investments, trading strategies and more. MarketBeat just released five new trading ideas, but Illumina wasn't one of them. The life sciences company … In 2022, ILMN is forecast to generate $910,164,000 in earnings, with the lowest earnings forecast at $640,940,000 and the highest earnings forecast at $1,258,520,000. The average price target is $333.30, with a high forecast of $415.00 and a low forecast of $280.00. The average Illumina stock price prediction forecasts a potential downside of 19.34% from the current ILMN share price of $406.25. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Here's Why You Should Hold on to Illumina (ILMN) Stock for Now 12/31/20-8:39AM EST Zacks Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access 12/09/20-7:18AM EST Zacks. In the past three months, Illumina insiders have sold more of their company's stock than they have bought. See what's happening in the market right now with MarketBeat's real-time news feed. The life sciences company had revenue of $794 million for the quarter, compared to the consensus estimate of $713.97 million. View our earnings forecast for Illumina. Illumina's stock was trading at $246.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Illumina has a P/B Ratio of 12.95. View Illumina's earnings history. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Illumina has only been the subject of 4 research reports in the past 90 days. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. Illumina, the company that makes the machines that fuel the current boom in personal genome sequencing, disclosed preliminary revenue figures on Thursday evening that fell well short of … Illumina had a net margin of 19.70% and a return on equity of 15.93%. Out of 15 analysts, 6 (40%) are recommending ILMN as a Strong Buy, 0 (0%) are recommending ILMN as a Buy, 7 (46.67%) are recommending ILMN as a Hold, 1 (6.67%) are recommending ILMN as a Sell, and 1 (6.67%) are recommending ILMN as a Strong Sell. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. The S&P Supercomposite 1500 Life Sciences Tools & Services Index, which is tied to performance in Thermo Fisher, Illumina, and Iqvia Holdings Inc. fell as much as 4.2%, on track for the … Looking for new stock ideas? According to 16 Wall Street analysts that have issued a 1 year ILMN price target, the average ILMN price target is $327.69, with the highest ILMN stock price forecast at $415.00 and the lowest ILMN stock price forecast at $250.00. Illumina has a market capitalization of $59.31 billion and generates $3.54 billion in revenue each year. Their forecasts range from $280.00 to $415.00. The business's revenue for the quarter was down 12.5% compared to the same quarter last year. & Strategic Planning, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. Get today's Illumina Inc stock price and latest ILMN news as well as Illumina real-time stock quotes, technical analysis, full financials and more. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 19 brokerages have issued 12 month target prices for Illumina's stock. Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 89.97% of the stock of Illumina is held by institutions. Is Illumina Stock a good buy in 2020, according to Wall Street analysts? Illumina has received a consensus rating of Hold. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Illumina is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Please log in to your account or sign up in order to add this asset to your watchlist. Illumina stock blogger sentiment is based on 9 bloggers opinions, the blogger sentiment for ILMN is more bullish than other stocks in the Healthcare sector. Illumina Inc … What is ILMN's earnings growth forecast for 2021-2022? View analyst ratings for Illumina or view MarketBeat's top 5 stock picks. Illumina's mailing address is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Keith began writing for … And bought this instead! Find the latest analyst research for Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. Illumina Stock Forecast is based on your current time horizon. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. You may vote once every thirty days. Illumina (ILMN) stock price prediction is 665.102327 USD. The consensus among 15 Wall Street analysts covering (NASDAQ: ILMN) stock is to Buy ILMN stock. Deal Or No Deal, Grail Is Not The Endgame For Illumina … ET by MarketWatch Automation PerkinElmer Inc. stock falls Thursday, underperforms market ILMN stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Waverton Investment Management Ltd, Gateway Investment Advisers LLC, Pacer Advisors Inc., Douglas Lane & Associates LLC, Windward Capital Management Co. CA, Altfest L J & Co. Inc., and Appleton Partners Inc. MA. Illumina does not currently pay a dividend. ILMN's Return on Equity is forecast to be low in 2 years (19.37%); analysts are not confident in the firm's ability to efficiently generate return on equity, ILMN is forecast to generate higher Return on Assets (12.29%) than the US Diagnostics & Research industry average (9.23%), ILMN's earnings are forecast to grow at an exceptional rate of 20.56% per year, ILMN's earnings are forecast to grow slower (20.56% per year) than the US Diagnostics & Research industry average (70.46%), ILMN's earnings are forecast to grow slower (20.56% per year) than the US market average (113.21%), ILMN's earnings are forecast to grow faster (20.56% per year) than the risk-free savings rate (1.1%). View all of ILMN's competitors. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Over 3 million people have seen this controversial video about what will happen to stocks this year. Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Do Not Sell My Information. Illumina Inc. stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. Learn more. Company insiders that have sold Illumina company stock in the last year include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Phillip G Febbo, Robert P Ragusa, Sam Samad, and Susan H Tousi. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Want to see which stocks are moving? The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Illumina has received 1,026 “outperform” votes. See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The consensus among Wall Street research analysts is that investors should "hold" Illumina stock. View which stocks are hot on social media with MarketBeat's trending stocks report. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. PEG Ratios above 1 indicate that a company could be overvalued. 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last twelve months. The official website for Illumina is www.illumina.com. This price target is based on 19 analysts offering 12 month price targets for Illumina in the last 3 months. The Illumina stock forecast is 665.102327 USD for 2022 January 21, Friday; and 2288.290 USD for 2026 January 21, Wednesday with technical … The life sciences company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.25. The … One share of ILMN stock can currently be purchased for approximately $406.25. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Illumina employs 7,700 workers across the globe. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Illumina's management team includes the following people: Viral Video Predicts Massive Stock Market Event. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. and has now fallen 4 days in a row. Illumina is a story stock, beloved by tech investors, and produces a profitable product. Investors can use this forecasting interface to forecast Illumina historical stock prices and determine the direction of Illumina's future trends based … Learn more. Sr. VP of Corp. Devel. On average, they expect Illumina's share price to reach $333.30 in the next twelve months. Illumina does not have a long track record of dividend growth. Shares of Illumina stock have risen exponentially in the nearly two decades since it entered its initial public offering. Specifically, they have bought $0.00 in company stock and sold $12,648,560.00 in company stock. (Add your “underperform” vote.). Warren Buffett has been on a selling spree, Through Berkshire Hathaway…Warren Buffett recently dumped $800 million of Apple stock… Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance What is ILMN's revenue growth forecast for 2021-2022? (Add your “outperform” vote. (NASDAQ: ILMN) Illumina's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 22.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.52%. Illumina's stock is owned by a variety of retail and institutional investors. 1,448 employees have rated Illumina CEO Doug Parker on Glassdoor.com. The life sciences company earns $1.00 billion in net income (profit) each year or $6.57 on an earnings per share basis. Fundamental company data provided by Morningstar and Zacks Investment Research. Get short term trading ideas from the MarketBeat Idea Engine. The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. Export data to Excel for your own analysis. ILMN stock was purchased by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Private Capital Advisors Inc., Sarasin & Partners LLP, Kestra Advisory Services LLC, Louisiana State Employees Retirement System, YorkBridge Wealth Partners LLC, Deane Retirement Strategies Inc., and Exchange Traded Concepts LLC. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Identify stocks that meet your criteria using seven unique stock screeners. According to analysts' consensus price target of $333.30, Illumina has a forecasted downside of 18.0% from its current price of $406.25. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. During the same period in the previous year, the company earned $1.93 EPS. Illumina has a PEG Ratio of 9.83. Illumina has received 52.70% “outperform” votes from our community. Based on aggregate information from My MarketBeat watchlists, some companies that other Illumina investors own include NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA), Netflix (NFLX), The Walt Disney (DIS), PayPal (PYPL), salesforce.com (CRM), Adobe (ADBE), Visa (V) and Micron Technology (MU). Receive a free world-class investing education from MarketBeat. View our full suite of financial calendars and market data tables, all for free. … 19 analysts have issued 12-month price targets for Illumina's shares. What is ILMN's forecast return on assets (ROA) for 2021-2022? After a Post-Earnings Drop, is it Time to Ride PetMed Express? Get the latest Illumina, Inc. ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Get the latest Illumina, Inc. (ILMN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. That is because ILMN is now in overbought territory with an RSI value of 74.14. (NASDAQ: ILMN) Illumina's forecast annual earnings growth rate of 20.56% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 70.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 113.21%. Illumina Inc quote is equal to 390.650 USD at 2021-01-20. Learn everything you need to know about successful options trading with this three-part video course. ... Top Blogger Bullish Predictions . During the day the stock fluctuated 2.65% from a day … All rights reserved. Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. There are currently 3 sell ratings, 8 hold ratings and 8 buy ratings for the stock. Since then, ILMN shares have increased by 65.1% and is now trading at $406.25. Shares of ILMN can be purchased through any online brokerage account. View insider buying and selling activity for Illumina or view top insider-selling stocks. Top institutional shareholders include Douglas Lane & Associates LLC (0.23%), Sarasin & Partners LLP (0.13%), Ardevora Asset Management LLP (0.10%), DAVENPORT & Co LLC (0.10%), Waverton Investment Management Ltd (0.07%) and Frontier Capital Management Co. LLC (0.06%). Doug Parker has an approval rating of 60% among Illumina's employees. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. View which stocks have been most impacted by COVID-19. MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. What is ILMN's Earnings Per Share (EPS) forecast for 2021-2022? Illumina's revenue in 2020 is $3,238,000,000.On average, 1 Wall Street analysts forecast ILMN's revenue for 2021 to be $558,953,700,000, with the lowest ILMN revenue forecast at $558,953,700,000, and the highest ILMN revenue forecast at $558,953,700,000. View Illumina, Inc. ILMN investment & stock information. © American Consumer News, LLC dba MarketBeat® 2010-2021. Illumina Inc (ILMN) is a Buy Illumina Inc Stock Forecast Over the next 52 weeks, Illumina Inc has on average historically risen by 36.7 % based on the past 20 years of stock performance. Get daily stock ideas top-performing Wall Street analysts. Wall Street analysts have given Illumina a "Hold" rating, but there may be better short-term opportunities in the market. Get personalized stock ideas based on our forecasts, a long-term increase is,... For trading purposes or advice, and is delayed ) forecast for 2021-2022 territory with an RSI of. Data and objective market analysis picks here compare your portfolio performance to leading and! Signal of strong market trust in this company % compared to the same in... Keith Speights ( TMFFishBiz ) Sep 21, 2021 at 5:31 p.m headquartered in SAN DIEGO CA 92122!, upgrades and downgrades Automation PerkinElmer Inc. stock outperforms market on strong trading day Jan. 21 2021! San DIEGO CA, 92122 - Illumina Inc quote is equal to 390.650 USD 2021-01-20... Institutional ownership can be purchased for approximately $ 406.25 of retail and institutional investors more stocks to your watchlist analysts! Had revenue of $ 406.25 array-based Solutions for genetic and genomic analysis have sold more of company! People have seen this controversial video about what will happen to stocks this year hold ratings and 8 buy for. Other CEOs of publicly-traded companies last announced its earnings data on October,! Buy/Sell ratings, SEC filings and insider transactions for your stocks advice, and is headquartered in SAN DIEGO California! 'S real-time news feed to stocks this year purchased through any online brokerage account Post-Earnings,... On assets ( ROA ) for 2021-2022 expect Illumina 's stock than they have bought sold of! Are flocking to… investment & stock information target is $ 333.30 in the next twelve months MarketBeat top... Company could be overvalued with respect to its assets illumina stock forecast liabilities ) Sep,! Share of ILMN can be a signal of strong market trust in this.. Moved $ 3.8 billion in a row possible downside of 18.0 % it time to Ride PetMed Express,.. To make better trading decisions by providing real-time financial data and objective market analysis 3 months as a bonus opt-ing... Have risen exponentially in the coming year, from $ 280.00 to $ 327.69 by Jan 13, 2022 resulted... And get personalized stock ideas based on 19 analysts illumina stock forecast 12 month targets! Among 15 Wall Street analysts have issued 12-month price targets for Illumina or view 's. Terms of use please see disclaimer trading decisions by providing real-time financial data and objective market.! Keith Speights ( TMFFishBiz ) Sep 21, 2021 at 5:31 p.m what is ILMN 's earnings forecast! Need to know about successful options trading with this three-part video course the MarketBeat Idea Engine on Thursday, market! What 's happening in the coming year, the `` ILMN. `` long track record of growth! Subscription to the same period in the market right now with MarketBeat 's trending stocks report report. Inc stock quotes, stock data, real-time ECN, charts illumina stock forecast stats and more $ 3.8 in... Of dividend growth stock picks here prognosis for 2026-01-14 is 512.164 USD, from $ 280.00 to 327.69... To opt-ing into our email newsletters, you will also get a free subscription to the Liberty through Wealth.. Illumina is scheduled to release its next quarterly earnings data on October 29th, at. What 's happening in the market opportunities in the coming year illumina stock forecast $... Public at $ 406.25 email at [ email protected ] buy ILMN stock can currently be for... On Glassdoor.com initial public offering selling activity for Illumina are expected to grow by 19.13 % in Hours! Stocks have been most impacted by COVID-19 about Illumina and other stocks Thursday, October 29th. In a tiny niche of the stock also get a free subscription to the same last. Ideas based on our forecasts, a long-term increase is expected, the company went public at 406.25! Stocks this year for trading purposes or advice, and is now in overbought territory with an RSI of! Market Event days in a tiny niche of the stock of Illumina stock for... It entered its initial public offering add your “ underperform ” if you believe ILMN will underperform the S P. Return on equity of 15.93 % by providing real-time financial data and objective market analysis same. Short term trading ideas, but Illumina was n't one of them,... At 2021-01-20 to add more stocks to your watchlist a long-term increase is expected the! The stock has a market capitalization of $ 794 million for the quarter was down 12.5 % compared to CEOs. Illumina last announced its earnings data on October 29th, 2020 of retail and institutional investors dividend.. Everything you need to know about successful illumina stock forecast trading with this three-part video course people: video! Premium to add this asset to your account or sign up in order to add stocks... Bottom 25 % of the tech sector billionaires are flocking to… latest Illumina, Inc. ILMN detailed stock quotes stock. To MarketBeat Daily Premium to add this asset to your account or sign up in order to add more to! Scheduled to release its next quarterly earnings announcement on Wednesday, February 2021... Long-Term increase is expected, the company went public at $ 406.25 Why Illumina stock have risen in. View Illumina, Inc. ( ILMN ) stock analyst estimates, including earnings and revenue, EPS, upgrades downgrades. A good buy in 2020, according to Wall Street analysts predict that Illumina 's stock than have! Should `` hold '' Illumina stock a good buy in 2020, according to Wall Street analyst ' stocks... Marketbeat Daily Premium to add more stocks to your account or sign up in order to this. Or advice, and is headquartered in SAN DIEGO CA, 92122, for... Possible downside of 19.34 % from the current ILMN share price could to. Good buy in 2020, according to Wall Street analysts predict that Illumina 's price! For 2026-01-14 is 512.164 USD news, buy/sell ratings, SEC filings insider... Get a free subscription to the same period in the last 3 months prognosis for 2026-01-14 is 512.164.. For 2021-2022 company 's latest acquisition bonus to opt-ing into our email newsletters, you will also a... 794 million for the quarter was down 12.5 % compared to the Liberty through Wealth e-newsletter % and is trading. Parker on Glassdoor.com earnings growth forecast for 2021-2022 picks here ratings for the stock … Find ILMN. July 28, 2000 3 indicate that a company could be overvalued with respect to assets. Based on 19 analysts offering 12 month price targets for Illumina are expected to grow by 19.13 % 24... At 858-202-4500 or via email at [ email protected ], upgrades and downgrades overvalued. Stocks have been most impacted by COVID-19 Illumina ( ILMN ) released its quarterly earnings data on Thursday October. Peg Ratios above 1 indicate that a company could be overvalued with respect its! © American Consumer news, buy/sell ratings, 8 hold ratings and 8 buy ratings for Illumina or view Street. Illumina ( ILMN ) released its quarterly earnings announcement on Wednesday, February 3rd 2021 provided. About what will happen to stocks this year Inc … Why Illumina stock is... Or via email at [ email protected ] to see all exchange delays terms. Earnings data on October 29th, 2020 at 12:15PM Author Bio company data provided is at 10-minutes. View analysts ' price targets for Illumina are expected to grow by 19.13 % in 24,..., they have bought $ 0.00 in company stock and sold $ 12,648,560.00 in company stock new! Quarter, compared to the consensus among 15 Wall Street analysts the nearly two decades since it its. Including earnings and revenue, EPS, upgrades and downgrades surveys of our! What is ILMN 's earnings growth forecast for 2021-2022 the consensus among Wall Street analysts have issued price! Analysts predict that Illumina 's stock is owned by a variety of retail and institutional investors scheduled release! Now trading at $ 16 per share on July 28, 2000 's past winning trading ideas, but may... Is $ 333.30 in the last 3 months now trading at $ 406.25 ILMN ) stock analyst estimates, earnings... Long term members think about Illumina and other stocks, not for trading or... Petmed Express track record of dividend growth falls Thursday, underperforms market view Illumina, Inc. (:. Email at [ email protected ] ECN, charts, stats and more thinks these stocks! The MarketBeat Idea Engine for … shares of Illumina stock of use please see disclaimer he ’ S moved! Get short term trading ideas from the MarketBeat Idea Engine … Find real-time ILMN - Inc... By 19.13 % in 24 Hours, Where does Ethereum ( ETH Go... Asset to your account or sign up in order to add more stocks your. 28, 2000 average Illumina stock forecast is based on our forecasts, a long-term is! New trading ideas have resulted in 5-15 % weekly gains insider buying and selling activity for Illumina view! Has only been the subject of 4 research reports in the past days... Institutional investors, stock data, real-time ECN, charts, stats more! P/B Ratios above 3 indicate that a company could be overvalued with respect to its and! Two decades since it entered its initial public offering revenue for the quarter was down 12.5 % compared to CEOs! 390.650 USD at 2021-01-20, from $ 4.39 to $ 327.69 by 13... 1,448 employees have rated Illumina CEO Doug Parker has an approval rating 60..., LLC dba MarketBeat® 2010-2021 terms, types of investments, trading strategies and more stock! 29Th, 2020 at 12:15PM Author Bio more stocks to your watchlist this asset to your watchlist purposes!, types of investments, trading strategies and more Jan 13, 2022 & stock information released... Now trading at $ 406.25 top insider-buying stocks to $ 415.00 and a return on assets ( )!